Health News

Apr 21, 2020 18:10 KST

Boehringer Ingelheim’s Aservo® EquiHaler® wins Red Dot for outstanding design quality

Boehringer Ingelheim is proud to announce that its Aservo® EquiHaler® received a Red Dot Award for product design. Aservo® EquiHaler® is an inhalant therapy licensed for use in horses with severe equi

Apr 21, 2020 16:36 KST

European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Boehringer Ingelheim today announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults.[2] The appro

Apr 21, 2020 16:32 KST

VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus

Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced positive topline data from Cara’s KALM-2 pivotal phase-III trial of KOR

Apr 16, 2020 14:24 KST

Ventilator Manufacturers Unite to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic

Several of the world’s ventilator manufacturers have formed a Ventilator Training Alliance (VTA) and partnered with Allego to create a mobile app that frontline medical providers can use to access a c

Apr 16, 2020 09:25 KST

Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer

Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN®[1] (trastuzumab) for the treatment of HER2-overexpressing breas

Apr 15, 2020 13:47 KST

Biolytic Introduces the Dr. Oligo 768XLc DNA RNA Synthesizer - Synthesizing 768 Oligos Just Got Faster

Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated in

Apr 14, 2020 13:53 KST

Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it is embedding secure video teleconferencing capabilities across the company’s global suite of

Apr 13, 2020 10:01 KST

Masimo Announces Full Market Release of Masimo SafetyNet™, a Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts

Masimo (NASDAQ: MASI) announced today the full market release of Masimo SafetyNet™, an innovative, economically scalable cloud-based patient management solution designed to help clinicians care for pa

Apr 09, 2020 17:29 KST

European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLC

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a mo

Apr 08, 2020 16:14 KST

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Boehringer Ingelheim has significantly stepped up its support to the fight against Covid-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine

Apr 08, 2020 13:54 KST

St. Luke’s University Health Network One of the First in the World to Pilot Masimo SafetyNet™, a Remote Patient Management Solution, to Aid Hospitalized COVID-19 Patients

Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the netw

Apr 08, 2020 12:56 KST

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) to develop a potential plasma-deri

Apr 08, 2020 09:00 KST

Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium longum BB536 in Infant Formula

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS (Generall

Apr 07, 2020 16:18 KST

LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors

LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation fact

Apr 03, 2020 13:00 KST

MAK's Oracle Water System Represents Device for Preventing COVID-19

“As it is harmless, I readily clean my hands using ‘Oracle Water’ after returning home, instead of other hand-detergents,” said a citizen of Daegu who was receiving the antiseptic solution at a commun

Apr 03, 2020 11:59 KST

Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context

Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To creat

Apr 02, 2020 14:11 KST

EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced initial preliminary findings from the Papa Giovanni XXIII Hospital sponsored SISCO (Siltuximab In

Apr 01, 2020 15:29 KST

Takeda Adopts Executive Compensation Recoupment Policy

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback policy”). The adoptio

Apr 01, 2020 13:04 KST

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) in Combination with CHP (Cyclophosphamide, Doxorubicin and Prednisone) for Treatment of Adult Patients with Previously Untreated Systemic Anaplastic Large Cell Lymphoma

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) granted a positive

Mar 31, 2020 13:57 KST

Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and

Mar 30, 2020 11:43 KST

DeltaTrak Announces New Non-Contact Forehead Infrared Thermometer to Aid in Coronavirus Prevention

DeltaTrak®, a leading innovator of cold chain management and temperature monitoring solutions, announces the immediate availability of the new Model 15004 Non-Contact Forehead Infrared Thermometer tha

Mar 30, 2020 10:13 KST

MAK's Oracle Water with Outstanding Cleansing and Sterilizing Power Demonstrates Effect of Preventing COVID-19

‘Oracle Water’, produced with Oracle Water System which is a powerful epidemics prevention solution developed by MAK, demonstrated the remarkable effect of preventing COVID-19. Oracle Water was beg

Mar 30, 2020 09:55 KST

Siemens Energy Korea relocates the office building to Chungjeong-ro

Siemens Energy Korea (Siemens Energy Ltd·SEL) said on March 30 that it relocate the office building to the Poongsan Building in Chungjeong-ro, Seoul. With the relocation, they announced its launch as

Mar 27, 2020 13:50 KST

ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients

Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin

Mar 26, 2020 14:13 KST

Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide

Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling COVID-19 through the International Medical Expert Communication Platform. The Handb

News by Region

News by Industry